A leading player in ophthalmology

Since its inception, Horus Pharma has enjoyed steady growth, driven by a strategy of continuous innovation and international expansion, which has established the company as a leading player in the field of eye health in Europe.

  • 116
    million € in turnover by 2025
  • 240
    employees
  • 70
    products
  • 42
    countries covered

Sustained growth

Turnover growth in millions of €

Horus Pharma Graphique évolution Du CA 1024 X 600 Px V2

  • Global expertise in ophthalmology

    Horus Pharma is developing a comprehensive range covering all eye health needs — from
    the most common to the rarest conditions — and supports healthcare professionals and
    patients at every stage of the care pathway.

    • 70 products
    • 5 complementary regulatory statuses
    Our history

  • Ongoing innovation, the driver of our growth

    Innovation at Horus Pharma is based on a pragmatic approach, focused on the continuous
    improvement of therapeutic solutions and addressing medical needs that remain
    inadequately met.

    • 10% of turnover invested in R&D each year
    Example of continuous innovation

  • An expanding international presence

    Horus Pharma is implementing a strategy of gradual and controlled internationalisation.

    • Over 15% of turnover generated outside France
    • A network of subsidiaries and partners covering 42 countries
    International, strategic pillar